Long-Term Survival Based on Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer

被引：0
|
作者：
Tiesi, Gregory
Stuart, Heather
Yakoub, Danny
Avisar, Eli
Merchant, Nipum
Livingstone, Alan S.
Franceschi, Dido
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)33969-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
221
引用
收藏
页码：S1175 / S1175
页数：1
相关论文
共 50 条
  • [21] Neutrophil to lymphocyte ratios and pathologic response to neoadjuvant therapy in esophageal cancer.
    Bronson, Nathan W.
    Luna, Renato
    Bloker, Lisa M.
    Douthit, Miriam A.
    Diggs, Brian S.
    Dolan, James P.
    Hunter, John G.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [22] Clinicopathologic Predictors of Long Term and Disease-Free Survival in Esophageal Adenocarcinomas with Complete Pathologic Response to Neoadjuvant Chemoradiation
    Agoston, A. T.
    Zheng, Y.
    Bueno, R.
    Lauwers, G. Y.
    Odze, R. D.
    Srivastava, A.
    LABORATORY INVESTIGATION, 2013, 93 : 142A - 142A
  • [23] Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer
    Gusella, M.
    Giacopuzzi, S.
    Bertolaso, L.
    Zanoni, A.
    Pezzolo, E.
    Modena, Y.
    Menon, D.
    Paganin, P.
    Weindelmayer, J.
    Crepaldi, G.
    De Manzoni, G.
    Pasini, F.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (03): : 252 - 257
  • [24] Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer
    M Gusella
    S Giacopuzzi
    L Bertolaso
    A Zanoni
    E Pezzolo
    Y Modena
    D Menon
    P Paganin
    J Weindelmayer
    G Crepaldi
    G De Manzoni
    F Pasini
    The Pharmacogenomics Journal, 2017, 17 : 252 - 257
  • [25] Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival
    Donahue, James M.
    Nichols, Francis C.
    Li, Zhuo
    Schomas, David A.
    Allen, Mark S.
    Cassivi, Stephen D.
    Jatoi, Aminah
    Miller, Robert C.
    Wigle, Dennis A.
    Shen, K. Robert
    Deschamps, Claude
    ANNALS OF THORACIC SURGERY, 2009, 87 (02): : 392 - 399
  • [26] Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer
    Reynolds, John Vincent
    Muldoon, Cian
    Hollywood, Donal
    Ravi, Narayanasamy
    Rowley, Suzanne
    O'Byrne, Ken
    Kennedy, John
    Murphy, Thomas J.
    ANNALS OF SURGERY, 2007, 245 (05) : 707 - 716
  • [27] Complete pathologic response to neoadjuvant chemoradiation is the only predictor of survival in patients with esophageal cancer
    Meredith, K. L.
    Weber, J.
    Siegel, E.
    McLoughlin, J.
    Taruga, K.
    Shah, N.
    Melis, M.
    Kelley, S.
    Karl, R.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 26 - 26
  • [28] Long-term survival improvement in esophageal cancer in the Netherlands
    Margreet, van Putten
    Judith, de Vos-Geelen
    Grard, Nieuwenhuijzen
    Peter, Siersema
    Valery, Lemmens
    Camiel, Rosman
    Maurice, van der Sangen
    Rob, Verhoeven
    ANNALS OF ONCOLOGY, 2017, 28
  • [29] Extent of Lymphadenectomy and Long-term Survival in Esophageal Cancer
    Gottlieb-Vedi, Eivind
    Kauppila, Joonas H.
    Mattsson, Fredrik
    Hedberg, Jakob
    Johansson, Jan
    Edholm, David
    Lagergren, Pernilla
    Nilsson, Magnus
    Lagergren, Jesper
    ANNALS OF SURGERY, 2023, 277 (03) : 429 - 436
  • [30] Response to neoadjuvant RCT as a predictor for overall survival in therapy of esophageal cancer
    Kirste, S.
    Mohammad, F.
    Murnik, M.
    Hoppner, J.
    Grosu, A.
    Nicolay, N.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1017 - S1017
12345